Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Effects on fertility

Description of key information

No relevant reproductive toxicity data were identified.

Effect on fertility: via oral route
Endpoint conclusion:
no study available
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

No relevant human or laboratory animal reproductive toxicity data were identified. However, availability considerations provide good support for the conclusion that a reproductive toxicity study can be waived.

 

Platinum is considered to be non-bioavailable following oral and dermal exposure, as evidenced by transformation/dissolution and bio-elution test data.

 

It is not expected to reach the lungs in appreciable quantities (based on respiratory tract deposition modelling data). Thus, inhalation will not be a significant route of exposure. Further, bio-elution test data indicates lack of bioavailability in lung fluid.

 

Since a chemical is required to be bioavailable in order to induce reproductive toxicity, platinum is not considered to pose a toxicity hazard to reproduction. Finally, for animal welfare reasons, conducting new in vivo toxicity tests is considered a last resort. Consequently, no testing for reproductive toxicity of platinum is considered justified.

Effects on developmental toxicity

Description of key information

No relevant developmental toxicity data were identified.

Effect on developmental toxicity: via oral route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

No relevant developmental toxicity data were identified. 

Toxicity to reproduction: other studies

Description of key information

No data identified.

Additional information

No relevant human or laboratory animal developmental toxicity data were identified. However, availability considerations provide good support for the conclusion that a developmental toxicity study can be waived.

 

Platinum is considered to be non-bioavailable following oral and dermal exposure, as evidenced by transformation/dissolution and bio-elution test data.

 

It is not expected to reach the lungs in appreciable quantities (based on respiratory tract deposition modelling data). Thus, inhalation will not be a significant route of exposure. Further, bio-elution test data indicates lack of bioavailability in lung fluid.

 

Since a substance is required to be bioavailable in order to induce reproductive/developmental toxicity, platinum is not considered to pose a toxicity hazard to development. Finally, for animal welfare reasons, conducting new in vivo toxicity tests is considered a last resort. Consequently, no testing for developmental toxicity of platinum is considered justified.

Mode of Action Analysis / Human Relevance Framework

No data identified.

Justification for classification or non-classification

No reproductive toxicity data are available for platinum. However, such effects are not expected, based on a lack of bioavailability following exposure via the oral, dermal and inhalation routes. As such, there is no evidence to classify it for reproductive toxicity according to EU CLP criteria (EC 1272/2008).

Additional information